Maxwerk

Maxwerk, formerly known as Grupo Maxwerk, was founded in 2007 and our focus is on Healthcare and the Pharmaceutical Industry, with locations in Mexico (Mexico City and Ocoyoacac Industrial Area), Germany (Düsseldorf, Nordrhein-Westfalen) and Cambridge Massachusetts. Our Divisions are: Maxwerk Engineering: We develop engineering and build pharmaceutical facilities complying with international GMP guidelines and audited by the strictest regulatory agencies: FDA, EMA, Cofepris, Invima, Anvisa. Our Customers are domestic and multinational Pharmaceutical Fortune 500 companies with production facilities in Mexico, Central America, the Caribbean (and some other LatAm countries). http://www.maxwerk.engineering/ Maxwerk Pharmaceutical: We supply pharmaceutical machinery and equipment. Maxwerk Biotechnology: Our team of scientists is working in the pipeline for developing novel products for Clinical and Research applications. Our focus is on Cardiovascular and Oncology. One Product of our pipeline has already been successfully approved by International Health Regulatory Authorities and is in the market licensed to a Multinational Pharmaceutical Company. Our Pipeline includes: diagnostic, theranostic and novel therapeutic agents. We expect to obtain further regulatory approvals for a second product in Q3 of 2021 and a third product between Q2-Q4 2022. We are continuously seeking talented individuals from the Pharmaceutical, Biotechnology and AI Sectors.

Sitio web

http://www.maxwerk.engineering/

Enlace externo para Maxwerk

Sector

Fabricación de productos farmacéuticos

Tamaño de la empresa

De 51 a 200 empleados

Sede

Ocoyoacac, México

Tipo

De financiación privada

Fundación

2007